Skip to main content

Sarepta Therapeutics Helps Biotech ETFs Buck Market Trend

Biotechnology sector-related exchange traded funds were among the few areas of the markets that shook off the tariffs-talk volatility and was still in the green Tuesday as Sarepta Therapeutics (NasdaqGS: SRPT) surged on positive preliminary results from its experimental treatment. The BioShares...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.